[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"postpartum-disorder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:postpartum-disorder":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,40,65,90],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100598402","preventing-perinatal-anxiety-testing-an-internet-delivered-intervention-100598402",false,"NCT07071025","Preventing Perinatal Anxiety: Testing an Internet-delivered Intervention","P-POD","Inclusion Criteria:\n\n* Pregnant and entering second trimester\n* In a romantic relationship\n* Partner must be agreeable to participate\n* State Trait Anxiety Inventory-Trait Total ≥ 44 and\u002For Obsessive Beliefs Questionnaire-44 Total ≥ 139\n\nExclusion Criteria:\n\n-Must speak English","ALL","18 Years",{"count":19,"type":20},100,"ESTIMATED","INTERVENTIONAL",[23],"NA","Postpartum anxiety disorders are the most prevalent postpartum psychiatric conditions. The purpose of this study is to evaluate the Internet-delivered postpartum anxiety and obsessive-compulsive disorder (OCD) prevention program, called \"Preventing Postpartum Onset Distress\", or P-POD. The overarching goal of this study is to conduct a randomized control trial of P-POD, an online program designed to reduce and prevent perinatal anxiety in at-risk women in West Virginia. Investigators will test the effects of P-POD compared to an anxiety education control intervention on risk factors for perinatal anxiety and assess mothers' anxiety symptoms, relationships with their partners, and relationships with their infants at 8-weeks postpartum. Eligible women and their partners will be consented at the start of the second trimester of pregnancy. Couples will be randomized into either the P-POD (active) or ANX-ED (control) intervention. Couples will then begin to work through the ten intervention modules: seven modules for women, at a recommended rate of one per week, and three modules for partners, at a recommended rate of no more than one per week. Women will complete brief weekly phone \"coaching calls\" to encourage module completion, ensure understanding of material, and answer any content-related or technical questions. Ten weeks after the pre-intervention assessment, women will complete the post-intervention assessment (same measures as pre-assessment).",[26],"Postpartum Disorder","NOT_YET_RECRUITING","2025-07-08",{"date":30,"type":31},"2025-07-17","ACTUAL",{"date":33,"type":20},"2025-08",{"date":35,"type":20},"2027-12",{"name":37,"class":38},"West Virginia University","OTHER",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":48,"minAge":17,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":21,"phases":51,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":39},"100491268","maternal-well-being-in-the-postnatal-stage-100491268","NCT05676918","Maternal Well-being in the Postnatal Stage","Maternal Well-being in the Postnatal Stage: Evaluation of Cognitive Biases and Validation of a Psychological Intervention","BIEMAT","Inclusion Criteria:\n\n* Women who have been mothers in the last year\n\nExclusion Criteria:\n\n* Women who have been mothers in the last month,\n* Women who meet the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for substance abuse and\u002For dependence within 30 days prior to study participation,\n* Women who have a serious mental disorder that makes it difficult to follow the protocol (e.g. serious neurocognitive problems or brain damage; schizophrenia and other psychotic disorders).","FEMALE",{"count":50,"type":20},98,[23],"The objective of this study is to design and validate an online intervention aimed at promoting well-being in women with postpartum depression. For this, the design of a multicomponent protocol consisting of empirically validated positive interventions and comparing these with a group Cognitive Behavioral Therapy (CBT) is proposed, following the National Institute for Health and Care Excellence (NICE) recommendations for the treatment of depression. Participants will be screened for inclusion in the program if they meet clinical criteria. After that, they will be randomly assigned to a CBT group or a positive psychology intervention (PPI) group.",[54,26],"Postpartum Depression","RECRUITING","2025-05-16",{"date":58,"type":31},"2025-05-21",{"date":60,"type":31},"2023-01-16",{"date":62,"type":20},"2026-03-01",{"name":64,"class":38},"Universidad Complutense de Madrid",{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":73,"sex":48,"minAge":17,"maxAge":74,"enrollmentInfo":75,"targetDuration":4,"studyType":21,"phases":77,"briefSummary":79,"conditions":80,"keywords":4,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":88,"locationsCount":39},"100429513","phase-4-treatment-to-regress-to-normoglycemia-in-women-with-a-recent-history-of-gdm-100429513","NCT04873050","Treatment to Regress to Normoglycemia in Women with a Recent History of GDM","A Randomized, Placebo-controlled, Double Blind Trial of Semaglutide 1mg (Ozempic®) on Regression to Normoglycemia in WomEn with a Recent History of Gestational DiabETes Mellitus: the SWEET Study","SWEET","Inclusion Criteria:\n\n1. Female\n2. 18 - 45 years old (inclusive)\n3. History of gestational diabetes in most recent pregnancy\n4. 6 months - 10 years postpartum\n5. BMI ≥ 25 kg\u002Fm2\n6. Use of long-acting reversible contraception or bilateral tubal ligation\n7. Dysglycemia as determined by glycemic response to 75g, 2-hour OGTT: either impaired fasting glucose (IFG), impaired glucose tolerance (IGT), or both (IFG\u002FIGT):\n\n   1. Fasting glucose 100-125mg\u002FdL (inclusive) and\u002For\n   2. 120 minute glucose 140-199mg\u002FdL (inclusive)\n8. Willingness to maintain physical activity level throughout study duration\n9. Willingness to standardize diet for 3 days prior to OGTT\n10. Ability to provide informed consent before any trial-related activities\n\nExclusion Criteria:\n\n1. Body weight \\> 350lb\n2. Pregnant or the intention of becoming pregnant or not using adequate contraceptive measures.\n3. Breastfeeding within 3 months of screening visit 1\n4. Post-menopausal\n5. Desiring pregnancy within study participation period or two months after participation ends (i.e. 10 months from enrolment)\n6. Use of tobacco products within past 6 months\n7. Substance or alcohol abuse\n8. Presence of significant systemic disease including: diabetes mellitus (type 1 or type 2), cardiac disease (e.g. congestive heart failure), renal impairment (e.g. serum creatinine levels ≥ 1.4 mg\u002FdL or eGFR \\\u003C 60), hepatic disease (including viral hepatitis, toxic hepatic damage, jaundice of unknown aetiology, or abnormal liver function tests), pancreatitis, uncontrolled thyroid disease (e.g. documented abnormal TSH), adrenal disease (including Cushing's syndrome, congenital adrenal hyperplasia), hyperlipidemia (fasting triglycerides \\> 399mg%), untreated or poorly controlled hypertension (resting blood pressure \\>159\u002F94 mmHg)\n9. History of or presence of: eating disorder, malignant disease requiring chemotherapy, or debilitating psychiatric disorder such as psychosis or neurological condition that could confound outcome variables\n10. History of bariatric surgery\n11. Use of medications for glucose regulation: insulin (e.g. Humalog, Novolog, Humulin), pramlintide, metiglinides, metformin, thiazolidinediones, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT2 inhibitors within four weeks of screening visit 1\n12. Use of medications for anti-obesity or weight loss within four weeks of screening visit 1\n13. Use of medications known to exacerbate glucose dysfunction (such as isotretinoin or corticosteroids) within four weeks of screening visit 1\n14. Known or suspected allergy to trial medication, excipients, or related products\n15. Contraindications to study medications: patients with a personal or family history of medullary thyroid cancer or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)\n16. Current or recent past (within 3 months) participation in another experimental drug trial\n17. Previous randomization in this trial\n18. Receipt of any investigational drug within 6 months prior to this trial",true,"45 Years",{"count":76,"type":20},102,[78],"PHASE4","The purpose of the study is to determine the efficacy of semaglutide 1mg (Ozempic®) to aid recently postpartum women with dysglycemia and a history of GDM to regress to normoglycemia; thereby filling a gap in efficacious pharmacologic intervention options for clinicians to support postpartum diabetes recovery and reduce future risk of T2DM in young women.",[81,26],"Pre Diabetes","2025-03-10",{"date":84,"type":31},"2025-03-13",{"date":86,"type":31},"2022-01-13",{"date":62,"type":20},{"name":89,"class":38},"Woman's",{"id":91,"slug":92,"hasResults":11,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":4,"eligibilityCriteria":96,"healthyVolunteers":11,"sex":48,"minAge":97,"maxAge":98,"enrollmentInfo":99,"targetDuration":4,"studyType":21,"phases":101,"briefSummary":102,"conditions":103,"keywords":104,"overallStatus":55,"whyStopped":4,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":39},"100551481","combined-effects-of-progressive-relaxation-techniques-along-with-benson-relaxation-techniques-100551481","NCT06460649","Combined Effects Of Progressive Relaxation Techniques Along With Benson Relaxation Techniques","Combined Effects Of Progressive Relaxation Techniques Along With Benson Relaxation Techniques on Stress Fatigue and Quality of Life on Postpartum Females","Inclusion Criteria:\n\n* • Parity of women must not more than 3 times\n\n  * Start from 2nd week of postpartum female\n  * Women with aged group of 20- 40 were included in study.(24)\n  * Women who had Vaginal or c section delivery were included in study.\n  * Women with no postnatal complications were included in study\n\nExclusion Criteria:\n\n* • Women with Diabetes Militias were excluded\n\n  * Women with Breast cancer were excluded\n  * Ovarian cancer were excluded\n  * Patient with dementia, delusional disorder were excluded\n  * Women who use Alcohol or substance abuse were excluded\n  * Women who had a history of psychiatric disorders were excluded\n  * Severed obesity ( BMI more than 40)","20 Years","40 Years",{"count":100,"type":20},54,[23],"The postpartum (or postnatal) period begins after childbirth and is typically considered to last for six weeks. Stress is considered a response to any stressor within external or internal milieu, to stay in an adaptive mode using functional or dysfunctional coping skills. It initiates an alterable mode that ultimately becomes a prolonged adaptive struggle The study will be a randomized controlled trial and will be conducted in Jinnah hospital, Lahore. This study will be completed in a time duration of 8 months after the approval of synopsis. Nonprobability convenience sampling technique will be used, and participants will be recruited in study after randomization. The subjects will be divided into two groups and group A will receive progressive relaxation technique along with Benson relaxing technique. and group B will receive progressive relaxation technique and deep breathing exercises will be used as a baseline treatment. The tools that will be used for pre and post treatment assessment are Postpartum fatigue scale (PFS), Perceived Stress Scale (PSS\\_10), WHOQOL-BREF Scale. The data will be assessed after 12 weeks. After data collection data will be analyzed by using SPSS version 25.",[26],[105,106,107,108,109,110],"Fatigue","Postpartum relaxation techniques","Postpartum period","Postpartum women","Quality of life","Stress","2024-06-11",{"date":113,"type":31},"2024-06-14",{"date":115,"type":31},"2023-12-10",{"date":117,"type":20},"2024-07-10",{"name":119,"class":38},"Riphah International University"]